NovaBay Pharmaceuticals (NBY) Shares Surge 19% Amid Strategic Pivot to Stablecoin Economy

TLDR

• NovaBay Pharmaceuticals’ stock climbed almost 19% following its announcement of a rebrand to Stablecoin Development Corporation.
• The firm’s ticker symbol will change from NBY to SDEV, effective April 3.
• NovaBay possesses 2.06 billion SKY tokens, equating to approximately 8.8% of the total supply, with an estimated value of $150 million.
• A $134 million private placement supported by Tether Investments and Framework Ventures financed the strategic shift.
• Even with Monday’s surge, the stock has still lost more than 95% of its value since the start of the year.

(SeaPRwire) –   NovaBay Pharmaceuticals experienced a stock increase of nearly 19% on Monday after revealing a complete strategic shift from eye care biotechnology to the stablecoin sector.

NovaBay Pharmaceuticals, Inc., NBY

The company announced its intention to rebrand as Stablecoin Development Corporation. Its trading symbol will be updated from NBY to SDEV, with the transition becoming official on April 3.

CEO Michael Kazley characterized the decision as a strong belief in digital finance. “The name change to Stablecoin Development Corporation reflects our conviction that stablecoins represent the most compelling structural opportunity in digital finance,” he stated.

This strategic redirection is not completely unexpected. In January, NovaBay submitted a filing with the SEC detailing its plan to function as an “on-chain holding company framework focused on long-duration participation in protocol-level digital asset ecosystems.”

NBY stock rose 19% to approximately $1.38–$1.40 on the announcement. However, the stock remains down over 95% for the year, indicating the jump occurred from a very low starting point.

Sky Token Holdings at the Center of the Strategy

The core of NovaBay’s new approach is its substantial holding of SKY, the governance token for the Sky protocol—the rebranded MakerDAO ecosystem responsible for issuing the USDS stablecoin.

As of March 16, the company holds about 2.06 billion SKY tokens. This amount constitutes roughly 8.8% of the total token supply, valued at approximately $150 million. According to CoinGecko, SKY is currently trading at $0.073, having increased around 15% this year despite a downturn in wider cryptocurrency markets.

This position was established using funds from a $134 million private placement finalized in January. Participants in that funding round were Framework Ventures, Tether Investments, and the Sky Frontier Foundation.

Staking Rewards and Future Plans

NovaBay’s staking initiative has already produced cumulative rewards of 26.6 million SKY tokens. The company indicated it intends to keep purchasing more SKY tokens on the open market.

SKY is presently the sole digital asset authorized under the company’s operating and risk management framework. However, NovaBay has identified yield-bearing stablecoins as a major focus area for the future.

The company referred to these instruments as “productive financial assets that unlock new primitives for savings, treasury management, and capital formation.”

NovaBay was established in 2000 in California and dedicated over twenty years to eye care biotech prior to this change.

The strategic move coincides with stablecoin regulation gaining momentum in Washington. Legislators recently achieved an “agreement in principle” on the treatment of stablecoin yield within a broader crypto market structure bill—a progression toward potential Senate Banking Committee legislation.

The company’s strategy is focused on holding protocol-aligned digital assets for long periods to engage in what it terms “protocol-level economic activity.”

Cumulative staking rewards currently amount to 26.6 million SKY tokens, and active initiatives are in progress to expand the holding further.